Last Updated on June 22, 2023

CNS and Neurological Disorders - Drug Targets- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Bentham Science Publishers B.V.

Abbreviation: CNS Neurol. Disord. - Drug Targets




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

2.87

SJR

 0.574

h-Index

 93

Rank

 9006

Important Details

Title CNS and Neurological Disorders - Drug Targets
Standard Abbreviation CNS Neurol. Disord. - Drug Targets
Type of Publication Journal
Discipline Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)
Impact Score 2.87
SCImago Journal Rank (SJR) 0.574
h-index 93
Overall Rank 9006
Publisher Name Bentham Science Publishers B.V.
Publication Country United Arab Emirates
International Standard Serial Number (ISSN) 18715273
Coverage and History 2006-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
634

About CNS and Neurological Disorders - Drug Targets


CNS and Neurological Disorders - Drug Targets is a journal published by Bentham Science Publishers B.V.. This journal covers the area[s] related to Medicine (miscellaneous), Pharmacology, Neuroscience (miscellaneous), etc. The coverage history of this journal is as follows: 2006-2022. The rank of this journal is 9006. This journal's impact score, h-index, and SJR are 2.87, 93, and 0.574, respectively. The ISSN of this journal is/are as follows: 18715273.

The best quartile of CNS and Neurological Disorders - Drug Targets is Q2. This journal has received a total of 634 citations during the last three years (Preceding 2022).


CNS and Neurological Disorders - Drug Targets Impact Score 2022-2023


The latest impact score (IS) of the CNS and Neurological Disorders - Drug Targets is 2.87. It is computed in the year 2023 as per its definition and based on Scopus data. 2.87

It is increased by a factor of around 0.11, and the percentage change is 3.99% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of CNS and Neurological Disorders - Drug Targets Impact Score 2023


Impact Score 2022 of CNS and Neurological Disorders - Drug Targets is 2.87. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of CNS and Neurological Disorders - Drug Targets. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.87
2021 2.76
2020 3.87
2019 3.27
2018 2.29
2017 1.83
2016 2.47
2015 2.22
2014 2.49

CNS and Neurological Disorders - Drug Targets h-index


  Table Setting

The h-index of CNS and Neurological Disorders - Drug Targets is 93. By definition of the h-index, this journal has at least 93 published articles with more than 93 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




CNS and Neurological Disorders - Drug Targets ISSN


The International Standard Serial Number (ISSN) of CNS and Neurological Disorders - Drug Targets is/are as follows: 18715273.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

CNS and Neurological Disorders - Drug Targets Ranking and SCImago Journal Rank (SJR)


The CNS and Neurological Disorders - Drug Targets is ranked 9006 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.574.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


CNS and Neurological Disorders - Drug Targets Publisher


Table Setting

The publisher of CNS and Neurological Disorders - Drug Targets is Bentham Science Publishers B.V.. The publishing house of this journal is located in the United Arab Emirates. Its coverage history is as follows: 2006-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of CNS and Neurological Disorders - Drug Targets is CNS Neurol. Disord. - Drug Targets. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('CNS Neurol. Disord. - Drug Targets') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in CNS and Neurological Disorders - Drug Targets


If your area of research or discipline is related to Medicine (miscellaneous), Pharmacology, Neuroscience (miscellaneous), etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of CNS and Neurological Disorders - Drug Targets?

The latest impact score of CNS and Neurological Disorders - Drug Targets is 2.87. It is computed in the year 2023.


What is the h-index of CNS and Neurological Disorders - Drug Targets?

The latest h-index of CNS and Neurological Disorders - Drug Targets is 93. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of CNS and Neurological Disorders - Drug Targets?

The latest SCImago Journal Rank (SJR) of CNS and Neurological Disorders - Drug Targets is 0.574. It is calculated in the year 2023.


What is the ranking of CNS and Neurological Disorders - Drug Targets?

The latest ranking of CNS and Neurological Disorders - Drug Targets is 9006. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of CNS and Neurological Disorders - Drug Targets?

CNS and Neurological Disorders - Drug Targets is published by Bentham Science Publishers B.V.. The publication country of this journal is United Arab Emirates.


What is the abbreviation of CNS and Neurological Disorders - Drug Targets?

This standard abbreviation of CNS and Neurological Disorders - Drug Targets is CNS Neurol. Disord. - Drug Targets.


Is "CNS and Neurological Disorders - Drug Targets" a Journal, Conference or Book Series?

CNS and Neurological Disorders - Drug Targets is a journal published by Bentham Science Publishers B.V..


What is the scope of CNS and Neurological Disorders - Drug Targets?

The scope of CNS and Neurological Disorders - Drug Targets is as follows:

  • Medicine (miscellaneous)
  • Pharmacology
  • Neuroscience (miscellaneous)

For detailed scope of CNS and Neurological Disorders - Drug Targets, check the official website of this journal.


What is the ISSN of CNS and Neurological Disorders - Drug Targets?

The International Standard Serial Number (ISSN) of CNS and Neurological Disorders - Drug Targets is/are as follows: 18715273.


What is the best quartile for CNS and Neurological Disorders - Drug Targets?

The best quartile for CNS and Neurological Disorders - Drug Targets is Q2.


What is the coverage history of CNS and Neurological Disorders - Drug Targets?

The coverage history of CNS and Neurological Disorders - Drug Targets is as follows 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
Entrepreneurship Theory and Practice Journal Wiley-Blackwell 338 185 12.75
Child and Family Social Work Journal Wiley-Blackwell Publishing Ltd 8628 67 2.20
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Syntax Journal Wiley-Blackwell Publishing Ltd 3422 29 0.93
Transnational Corporations Journal UNCTAD United Nations Conference on Trade and Development 6120 27 1.92
Studies in Continuing Education Journal Routledge 6011 38 2.81
Indian Phytopathology Journal Springer Nature 14222 11 1.33
Journal des Professionnels de l'Enfance Journal TPMA 27577 2 0.00

Check complete list




CNS and Neurological Disorders - Drug Targets Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 2.87
2021 2.76
2020 3.87
2019 3.27
2018 2.29
2017 1.83
2016 2.47
2015 2.22
2014 2.49



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

See All

Top Journals/Conferences in Neuroscience (miscellaneous)

Nature Neuroscience
Nature Publishing Group | United Kingdom

Annual Review of Neuroscience
Annual Reviews Inc. | United States

Neuron
Cell Press | United States

Nature Reviews Neuroscience
Nature Publishing Group | United Kingdom

EMBO Journal
Wiley-Blackwell | Germany

Trends in Neurosciences
Elsevier Ltd. | United Kingdom

Nature Aging
Springer | Germany

eLife
eLife Sciences Publications | United Kingdom

PLoS Biology
Public Library of Science | United States

Current Opinion in Neurobiology
Elsevier Ltd. | United Kingdom

Current Biology
Cell Press | United States

Stroke
American Heart Association | United States

Progress in Neurobiology
Elsevier Ltd. | United Kingdom

Journal of Neuroinflammation
BioMed Central Ltd. | United Kingdom

Journal of Neuroscience
Society for Neuroscience | United States

See All